We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+14.72%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
AUM
$82.1M
AUM Growth
+$6.66M
Cap. Flow
-$5.88M
Cap. Flow %
-7.16%
Top 10 Hldgs %
27.02%
Holding
130
New
39
Increased
22
Reduced
26
Closed
36

Top Sells

Rank Stock Value
1
RRC icon
Range Resources
RRC
+$1.82M
2
CI icon
Cigna
CI
+$1.7M
3
WBA
Walgreens Boots Alliance
WBA
+$1.34M
4
CRM icon
Salesforce
CRM
+$1.33M
5
BIIB icon
Biogen
BIIB
+$1.29M

Sector Composition

Rank Sector Weight
1 Healthcare 38.36%
2 Technology 10.83%
3 Communication Services 6.32%
4 Energy 4.64%
5 Consumer Discretionary 4.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PDCO
51
DELISTED
Patterson Companies, Inc.
PDCO
$603K 0.73%
13,338
+2,099
+19% +$91.1K
AMT icon
52
American Tower
AMT
$76.7B
$577K 0.7%
+4,747
New +$522K
HLF icon
53
Herbalife
HLF
$1.32B
$552K 0.67%
+18,984
New +$528K
V icon
54
Visa
V
$686B
$533K 0.65%
+5,993
New +$516K
MOH icon
55
Molina Healthcare
MOH
$10B
$508K 0.62%
11,149
+6,009
+117% +$314K
JAZZ icon
56
CALL
Jazz Pharmaceuticals
JAZZ
$16.3B
$493K 0.6%
+3,400
New +$443K
ICLR icon
57
Icon
ICLR
$12.6B
$480K 0.58%
+6,018
New +$493K
MSFT icon
58
Microsoft
MSFT
$3.63T
$456K 0.56%
+6,917
New +$443K
PYPL icon
59
PayPal
PYPL
$49.9B
$455K 0.55%
10,587
-11,577
-52% -$484K
ALDR
60
DELISTED
Alder Biopharmaceuticals
ALDR
$454K 0.55%
21,805
-41,766
-66% -$925K
VYGR icon
61
Voyager Therapeutics
VYGR
$187M
$452K 0.55%
34,143
-113
-0.3% -$1.37K
ZION icon
62
Zions Bancorporation
ZION
$10.4B
$442K 0.54%
+10,520
New +$457K
MYOK
63
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$407K 0.5%
30,957
-1,539
-5% -$19.7K
ZAYO
64
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$382K 0.47%
11,619
-37,258
-76% -$1.19M
CHRS icon
65
Coherus Oncology
CHRS
$227M
$343K 0.42%
+16,209
New +$399K
ELGX
66
DELISTED
Endologix Inc
ELGX
$333K 0.41%
4,593
+1,944
+73% +$129K
MDCO
67
CALL
DELISTED
Medicines Co
MDCO
$323K 0.39%
+6,600
New +$301K
RGNX icon
68
Regenxbio
RGNX
$673M
$314K 0.38%
16,277
+4,828
+42% +$93.1K
VMC icon
69
Vulcan Materials
VMC
$37.2B
$300K 0.37%
2,488
+801
+47% +$98K
XYZ
70
Block Inc
XYZ
$50.2B
$286K 0.35%
+16,548
New +$259K
CSII
71
DELISTED
Cardiovascular Systems, Inc.
CSII
$263K 0.32%
9,301
-428
-4% -$11.4K
ARAY icon
72
Accuray
ARAY
$34.1M
$251K 0.31%
52,934
+5,225
+11% +$27.2K
CRUS icon
73
Cirrus Logic
CRUS
$6.57B
$240K 0.29%
3,951
-6,149
-61% -$350K
NVRO
74
DELISTED
NEVRO CORP.
NVRO
$229K 0.28%
+2,445
New +$221K
EVH icon
75
Evolent Health
EVH
$345M
$226K 0.28%
+10,135
New +$195K

Similar funds

Partner Investment Management's Q1 2017 Portfolio in Review

As of Q1 2017, Partner Investment Management held 130 positions worth $82.1M, up 8.8% from $75.5M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Partner Investment Management withdrew a net $5.88M in Q1 2017, closing 36 positions and reducing 26 holdings. Its most notable exit was Range Resources, an estimated $1.82M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 42% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Partner Investment Management opened a new position in Liberty Global Class A worth $2.32M.

  • Partner Investment Management's largest Q1 2017 buy was Liberty Global Class A: 64,720 shares worth $2.32M.
  • Partner Investment Management added most to Marvell Technology in Q1 2017, an estimated $2.07M increase.
  • Partner Investment Management's biggest Q1 2017 reduction was Cigna, cutting an estimated $1.7M.
  • Partner Investment Management fully exited Range Resources in Q1 2017, selling an estimated $1.82M.
  • Partner Investment Management's ten largest holdings make up 27% of its $82.1M portfolio in Q1 2017.
  • Partner Investment Management opened 39 new positions and closed 36 in Q1 2017.
  • Partner Investment Management's portfolio value rose 8.8% quarter-over-quarter to $82.1M.

Based on Partner Investment Management's 13F filing for Q1 2017, filed 15 May 2017.